Search

Your search keyword '"Carol Forsblom"' showing total 334 results

Search Constraints

Start Over You searched for: Author "Carol Forsblom" Remove constraint Author: "Carol Forsblom"
334 results on '"Carol Forsblom"'

Search Results

251. Arterial stiffness and vascular complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study

252. Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately

253. Genetic polymorphisms in nitric oxide synthase 3 gene and implications for kidney disease: a meta-analysis

254. Cumulative cost of prescription medication in outpatients with type 1 diabetes in Finland

255. Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension

256. Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes

257. DDOST, PRKCSH and LGALS3, which encode AGE-receptors 1, 2 and 3, respectively, are not associated with diabetic nephropathy in type 1 diabetes

258. Effects of long-term fenofibrate treatment on markers of renal function in type 2 diabetes: the FIELD Helsinki substudy

259. Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study)

260. A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes

261. Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes

262. Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes

263. Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial

264. Estimation of VLDL, IDL, LDL, HDL2, apoA-I, and apoB from the Friedewald inputs--apoB and IDL, but not LDL, are associated with mortality in type 1 diabetes

265. Early autonomic dysfunction in type 1 diabetes: a reversible disorder?

266. Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism

267. Effect of parental type 2 diabetes on offspring with type 1 diabetes

268. G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes

269. Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes

270. Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes

271. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes

272. Increased levels of alpha-defensin (-1, -2 and -3) in type 1 diabetic patients with nephropathy

273. Physical activity and diabetes complications in patients with type 1 diabetes: the Finnish Diabetic Nephropathy (FinnDiane) Study

274. HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes

275. Association analysis of podocyte slit diaphragm genes as candidates for diabetic nephropathy

276. Relationship between lipid profiles and kidney function in patients with type 1 diabetes

277. Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes

278. Leisure-time physical activity is associated with the metabolic syndrome in type 1 diabetes: effect of the PPARgamma Pro12Ala polymorphism: the FinnDiane Study

279. Podocyte apoptosis is prevented by blocking the Toll-like receptor pathway

280. Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study

281. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy

282. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene

283. Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum

284. Low birth weight does not increase the risk of nephropathy in Finnish type 1 diabetic patients

285. Complex relationship between blood pressure and mortality in type 2 diabetic patients: a follow-up of the Botnia Study

286. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study)

287. The C/C-13910 genotype of adult-type hypolactasia is associated with an increased risk of colorectal cancer in the Finnish population

288. Leisure time physical activity is associated with poor glycemic control in type 1 diabetic women: the FinnDiane study

289. Birth weight is inversely correlated to adult systolic blood pressure and pulse pressure in type 1 diabetes

290. Altered age-related blood pressure pattern in type 1 diabetes

291. The genetic variant of lactase persistence C (-13910) T as a risk factor for type I and II diabetes in the Finnish population

292. Dopamine D3 receptor gene polymorphisms, blood pressure and nephropathy in type 1 diabetic patients

293. Implementation of guidelines for the prevention of diabetic nephropathy

294. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients

295. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

296. Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

297. Polymorphisms in the nephrin gene and diabetic nephropathy in type 1 diabetic patients

298. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients

299. Erratum to: Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes

300. A gene conferring susceptibility to type 2 diabetes in conjunction with obesity is located on chromosome 18p11

Catalog

Books, media, physical & digital resources